[SIGNALING MECHANISM OF CARDIOPROTECTIVE EFFECT OF REACTIVE OXYGEN SPECIES].

Critical role of mitochondrial ROS is dependent on their site of production on the electron transport chain in ischemic heart. Am J Cardiovasc Dis (2016) 0.79

[Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart]. Izv Akad Nauk Ser Biol (2007) 0.99

Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med (2005) 0.85

Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. Bull Exp Biol Med (2002) 0.85

Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. Bull Exp Biol Med (2001) 0.83

[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors]. Eksp Klin Farmakol (2002) 0.82

Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels. Bull Exp Biol Med (2007) 0.82

[Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations]. Eksp Klin Farmakol (2007) 0.80

[Cardioprotective effect of remote ischemic preconditioning]. Angiol Sosud Khir (2009) 0.80

[Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use]. Angiol Sosud Khir (2012) 0.80

Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci (1999) 0.79

[Reactive oxygen species are triggers and mediators of an increase in cardiac tolerance to impact of ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2015) 0.79

[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress]. Eksp Klin Farmakol (1995) 0.78

Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. Bull Exp Biol Med (2002) 0.78

Role of Intracellular Calcium and Cyclic Nucleotides in Realization of Cardioprotective Effects of δ(1)- and κ(1)-Opioid Receptor Agonists. Bull Exp Biol Med (2009) 0.78

[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors]. Ross Fiziol Zh Im I M Sechenova (2002) 0.78

Cardioprotective effect of kappa1-opioid receptor activation and role of cAMP in its realization. Bull Exp Biol Med (2007) 0.78

[Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction]. Vestn Ross Akad Med Nauk (2013) 0.77

[Antiarrhythmic effect of the antiopioid peptide nociceptin and its effect on fast Na+-channels in cardiomyocytes]. Biull Eksp Biol Med (1998) 0.77

[Delta-opioid receptor agonists prevent the irreversible damage of cardiomyocytes in ischemized-reperfused isolated rat heart]. Eksp Klin Farmakol (2005) 0.77

[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.77

[Problem of end-effector of ischemic postconditioning of the heart]. Ross Fiziol Zh Im I M Sechenova (2013) 0.77

[The role of sarcolemmal and mitochondrial K(ATP)-channels in realization of the cardioprotection and antiarrhythmic effect of different regimens of hypobaric adaptation]. Ross Fiziol Zh Im I M Sechenova (2009) 0.77

Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion. Bull Exp Biol Med (2008) 0.77

Functional state of myocardial mitochondria in ischemia reperfusion of the heart in rats adapted to hypoxia. Bull Exp Biol Med (2014) 0.77

[Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?]. Biull Eksp Biol Med (1997) 0.77

[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Ross Fiziol Zh Im I M Sechenova (2001) 0.77

Opioid receptors and heart resistance to arrhythmogenic factors. Bull Exp Biol Med (2004) 0.77

[The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea]. Eksp Klin Farmakol (1997) 0.77

[Anti-arrhythmia effects of enkephalinase inhibitors]. Eksp Klin Farmakol (2001) 0.76

[Effect of cold stress on the contractile activity, carbohydrate and energy metabolism in the isolated rat heart]. Patol Fiziol Eksp Ter (1997) 0.76

[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol (2000) 0.76

[Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use]. Kardiologiia (2010) 0.76

Receptor specificity of the antiarrhythmic effect produced by opioid peptides Dalargin and DADLE during myocardial reperfusion. Bull Exp Biol Med (2002) 0.76

[Role of kappa-opioid receptors in the regulation of cardiac resistance to arrhythmogenic effects of ischemia and reperfusion]. Ross Fiziol Zh Im I M Sechenova (2006) 0.76

[Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists]. Eksp Klin Farmakol (2001) 0.76

Stimulation of mu and delta-Opiate Receptors and Tolerance of Isolated Heart to Oxidative Stress: the Role of NO-Synthase. Biochemistry (Mosc) (2001) 0.76

Cardiac contractility after transplantation of autologous mononuclear bone marrow cells in patients with myocardial infarction. Bull Exp Biol Med (2006) 0.76

[Role of heat shock proteins, aldose reductase, Bcl-2 protein and microRNA in the mechanism of delayed preconditioning of heart]. Ross Fiziol Zh Im I M Sechenova (2010) 0.76

[Signaling mechanism of neuroprotective effect of ischemic preconditioning of brain]. Patol Fiziol Eksp Ter (2013) 0.76

[Trigger mechanism of adaptive phenomenon of ischemic heart postconditioning]. Ross Fiziol Zh Im I M Sechenova (2012) 0.76

[Effect of a Rhodiolae rosea extract on the level of inducible HSP-70 in the myocardium under stress]. Biull Eksp Biol Med (1996) 0.76

Cardioprotective Activity of Ganoderma lucidum Extract during Total Ischemia and Reperfusion of Isolated Heart. Bull Exp Biol Med (2015) 0.75

[Neuroprotective and cardioprotective effects of hypothermic preconditioning]. Patol Fiziol Eksp Ter (2012) 0.75

K(ATP) channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat ventricular myocytes. Exp Ther Med (2012) 0.75

[Anti-arrhythmic effect of phytoadaptogens]. Eksp Klin Farmakol (2000) 0.75

[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.75

[Effect of stimulation of mu-opiate receptors on contractility of the isolated heart in normal oxygenation and during ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75

Cardioprotective effect of ischemic postconditioning on the model of isolated heart. Bull Exp Biol Med (2012) 0.75

[Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion]. Patol Fiziol Eksp Ter (2004) 0.75

[The antiarrhythmic effect of (-)-U-50,488 in rats with acute ischemia and reperfusion of heart is mediated by kappa1-opioid receptor activation]. Eksp Klin Farmakol (2005) 0.75

[Significance of opioid receptors in regulation of cardiac tolerance in pathogenic impact of long-term ischemia-reperfusion in vivo]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75

Participation of central kappa-opioid receptor in arrhythmogenesis. Life Sci (1997) 0.75

[The role of delta-1 opiate receptors in regulation of contractility in isolated rat heart during normal oxygenation and ischemia-reperfusion]. Izv Akad Nauk Ser Biol (2004) 0.75

[Contribution of the endogenous opioid system to regulation of heart resistance to the arrhythmogenic effect of short-term ischemia and reperfusio]. Izv Akad Nauk Ser Biol (2005) 0.75

[mu-Opiate receptor activation and increase in heart resistance to ischemic and reperfusion injury]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75

Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis. Clin Exp Pharmacol Physiol (1999) 0.75

[Blood-brain barrier permeability for the ligands of opioid receptors]. Eksp Klin Farmakol (2002) 0.75

[Delta-opioid receptor activation prevents appearance of irreversible damages of cardiomyocytes and exacerbates myocardial contractility dysfunction during ischemia and reperfusion]. Patol Fiziol Eksp Ter (2007) 0.75

[The effect of stimulation of cardiac delta1-opioid receptors on the resistance of isolated heart to the action of ischemia and reperfusion]. Eksp Klin Farmakol (2006) 0.75

[Intracellular mechanisms of opioidergic regulation of the myocardial function during normoxia and postischemic reperfusion]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75

[Comparative study of the antiarrhythmic activity of mu- and delta-opioid receptor agonists during acute cardiac ischemia and reperfusion models in rats]. Eksp Klin Farmakol (2006) 0.75

[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion]. Eksp Klin Farmakol (2012) 0.75

[Modulating effect of mu-opioid receptor ligands on adrenergic mechanism of stressor heart damage pathogenesis]. Biull Eksp Biol Med (1998) 0.75

[Prevention of arrhythmia by periodic hypoxia is mediated by activation of mu- and delta-opioid receptors]. Biull Eksp Biol Med (1998) 0.75

[The mechanism of the anti-arrhythmia action of opioid receptor agonists and antagonists]. Biull Eksp Biol Med (1993) 0.75

[The role of peripheral and central mu-opiate receptors in the modulation of adrenergic cardiac lesions during stress]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75

[Peripheral mu-opiate receptors and regulation of cardiac resistance to arrhythmogenic effects]. Biull Eksp Biol Med (1998) 0.75

[Opiatergic mechanisms of cardioprotective and anti-arrhythmic effects of adaptation]. Biull Eksp Biol Med (1999) 0.75

[Diurnal fluctuations of plasma renin activity and aldosterone level in patients with arterial hypertension]. Kardiologiia (1990) 0.75

[The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias]. Eksp Klin Farmakol (1998) 0.75

[Effect of enkephalins on biosynthesis of myocardial proteins during acute exposure to cold]. Vopr Med Khim (1999) 0.75

[The mechanism of the antiarrhythmic action of dalargin in experimental myocardial ischemia]. Eksp Klin Farmakol (1992) 0.75

[Central kappa1-opioid receptors and arrhythmogenesis mechanism]. Biull Eksp Biol Med (1999) 0.75

Effect of opiate peptide dalargin and des-Tyr-dalargin on cardiac pump function during ischemia-reperfusion. Bull Exp Biol Med (2004) 0.75

[Modulation of the antiarrhythmic effect by endogenous opioids during adaptation to hypoxia in rats]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75

[The participation of different types of opiate receptors in the mechanism of cardiac stressor damage]. Fiziol Zh Im I M Sechenova (1997) 0.75

[Opiatergic mechanisms of antiarrhythmic effect of adaptation]. Biull Eksp Biol Med (1996) 0.75

[Endorphin component of endogenic opioid system: location, reception, function]. Patol Fiziol Eksp Ter (2004) 0.75

[The participation of the central and peripheral kappa-opiate receptors in the mechanism of the anti-arrhythmia action of benzeneacetamide derivatives]. Eksp Klin Farmakol (1997) 0.75

[Opioid peptides in the dynamics of "physiological" and "pathological" stress]. Patol Fiziol Eksp Ter (1991) 0.75

[Significance of delta1-opioid receptors for regulation of the isolated heart resistance to ischemia-reperfusion]. Kardiologiia (2003) 0.75

[The participation of prostanoids in the realization of the cardioprotective, antistressor and anti-arrhythmic effects of enkephalins]. Vestn Ross Akad Med Nauk (1992) 0.75

[The role of cnetral and peripheral mu and delta opiate receptors in the realization of the anti-arrhythymic effect of adaptation]. Biull Eksp Biol Med (1996) 0.75

[The role of endogenous opioid peptides in the mechanisms of the antiarrhythmic effect of adaptation]. Fiziol Zh Im I M Sechenova (1997) 0.75

[Mechanism of the anti-arrhythmic effect of Rhodiola rosea extract]. Biull Eksp Biol Med (1998) 0.75

[Pathogenesis of impaired cardiac electric stability in experimental hypodynamia]. Patol Fiziol Eksp Ter (1997) 0.75

[The role of opiate receptors and ATP-dependent potassium channels of mitochondria in the formation of myocardial adaptive resistance to the arrhythmogenic effect of ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2004) 0.75

[The use of opiate receptor ligands for correction of heart electrical instability]. Biull Eksp Biol Med (1998) 0.75

[Effect of gamma-oxybutyrate on energy metabolism and the cyclic nucleotide level in nerve tissue in experimental intracerebral hemorrhage]. Farmakol Toksikol (1987) 0.75

[Opioid system and cardiac resistance to ischemic and reperfusion injuries]. Ross Fiziol Zh Im I M Sechenova (2000) 0.75

[The anti-arrhythmic effect of the mu-opiate receptor agonists in adrenal arrhythmia: the role of the autonomic nervous system]. Biull Eksp Biol Med (1996) 0.75

[Change in the opioid peptide level in the heart and blood plasma during acute myocardia ischemia complicated by ventricular fibrillation]. Vopr Med Khim (1992) 0.75

[The effect of K(ATP)-channel activation on the electrical stability of myocardium in rats with postinfarction cardiosclerosis]. Eksp Klin Farmakol (2004) 0.75